As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
Safety was equally impressive. ENV-294 was well tolerated
The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options
Board approves five-year appointment, subject to shareholder nod through postal ballot
Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
Company leadership is framing the move as transformational.
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
Subscribe To Our Newsletter & Stay Updated
